By API User
22 September 2025 | Sydney, Australia – LTR Pharma Limited (ASX:LTP), a clinical-stage pharmaceutical company focused on rapid-acting intranasal therapies, is pleased to announce that it has secured a 33% equity stake in LevOmega Pty Ltd at no cost to shareholders. This investment provides LTR Pharma with new exposure to the global multi-billion-dollar omega-3 market, … Continued
By API User
Key Facts: Federal Government launches $1.1 billion ten-year Cleaner Fuels Program to boost low-carbon liquid fuel production in Australia EcoPHA developing world's first integrated process to produce both renewable biofuels and marine-biodegradable bioplastics from Pongamia oil Project could contribute $1 billion to national economy and create thousands of regional jobs across plantations, refining and product … Continued
By API User
Perth, Australia – 18 September 2025 | BlinkLab Limited (ASX:BB1), a leading digital health company developing AI-powered smartphone-based diagnostic tools, has today announced that it has engaged The Vanderbilt Kennedy Center in Nashville, Tennessee as its seventh U.S. clinical research site for its ongoing pivotal FDA 510(k) diagnostic trial aimed at autism. Seventh U.S. clinical … Continued
By API User
Key Highlights: PANCOSIL is the first in the world study administering OncoSil™ via direct injection through the skin (percutaneous) under CT-imaging guidance for treatment of locally advanced pancreatic cancer (LAPC) Preliminary results from the PANCOSIL Investigator Initiated Study presented at the CIRSE 2025 Congress demonstrate it is both safe and feasible to deliver OncoSil™ by … Continued
By API User
Perth, Australia – 17 September 2025 | BlinkLab Limited (ASX:BB1), a digital health company developing smartphone-based diagnostic tools for neurodevelopmental conditions, has today announced a further expansion of its U.S. clinical trial site network with the engagement of the Thompson Center for Autism & Neurodevelopment at the University of Missouri. The Center will assist in … Continued
By API User
Highlights • In collaboration with a leading global pharmaceutical company, 4DMedical launches a lung health screening program in Brazil, focusing on lung cancer screening and detecting incidental findings like coronary artery calcification and COPD • Royal Melbourne Hospital will pilot 4DMedical’s full portfolio for advanced lung ventilation analysis and clinical imaging assessment of lung health • … Continued
By API User
4DMedical gains U.S. CMS reimbursement for CT:VQ™ Highlights U.S. Centers for Medicare & Medicaid Services (CMS) confirm reimbursement for CT:VQ™, accelerating the path to broad market adoption CT:VQ™ will be reimbursed as a New Technology Ambulatory Payment Classification (APC) at US$650.50 per scan under the Hospital Outpatient Prospective Payment System (OPPS) CMS will pay the … Continued
By API User
Melbourne, Australia, 4 September 2025 – CUREator, the Brandon BioCatalyst biotech Incubator, today announced $1.23 million in top-up funding for six high-performing participants from their Preclinical and Minimising Antimicrobial Resistance Streams. CUREator top-up funding was awarded through a competitive process by each stream’s Investment Review Committee, based on the progress made with initial project funding … Continued
By API User
NeuroScientific Biopharmaceuticals Reports Positive Outcomes from StemSmart™ MSC Therapy in Renal Transplantation Sydney, Australia – 27 August 2025 – NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) today announced promising results from two clinical studies evaluating its proprietary StemSmart™ mesenchymal stromal cell (MSC) therapy in renal transplantation. The findings provide strong support for further clinical development aimed at improving … Continued
By API User
Perth, Australia – 26 August 2025 – BlinkLab Limited (ASX:BB1), a digital health company developing AI-powered smartphone-based diagnostic tools for neurodevelopmental conditions, today announced the expansion of its U.S. clinical trial network with the addition of two globally renowned institutions: Cincinnati Children’s Medical Center and Seattle Children’s Research Institute. Both centres will participate in BlinkLab’s … Continued
